Show simple item record

dc.contributor.authorVaughan, Patricia S.
dc.contributor.authorAziz, Farah
dc.contributor.authorVan Wijnen, Andre J.
dc.contributor.authorWu, Shujian
dc.contributor.authorHarada, Hisashi
dc.contributor.authorTaniguchi, Tadatsugu
dc.contributor.authorSoprano, Kenneth J.
dc.contributor.authorStein, Janet L.
dc.contributor.authorStein, Gary S.
dc.date2022-08-11T08:08:50.000
dc.date.accessioned2022-08-23T16:09:40Z
dc.date.available2022-08-23T16:09:40Z
dc.date.issued1995-09-28
dc.date.submitted2009-01-13
dc.identifier.citationNature. 1995 Sep 28;377(6547):362-5. <a href="http://dx.doi.org/10.1038/377362a0">Link to article on publisher's site</a>
dc.identifier.issn0028-0836 (Print)
dc.identifier.doi10.1038/377362a0
dc.identifier.pmid7566094
dc.identifier.urihttp://hdl.handle.net/20.500.14038/32753
dc.description.abstractThe human histone H4 gene FO108 is regulated during the cell cycle with a peak in transcription during early S phase. The cell-cycle element (CCE) required for H4 histone activation is a sequence of 11 base pairs that binds a protein factor in electrophoretic mobility shift assays that has been designated histone nuclear factor M (HiNF-M). Here we report the purification of HiNF-M, and show it to be a protein of relative molecular mass (M(r)) 48K that is identical to interferon (IFN) regulatory factor 2 (IRF-2), a negative transcriptional regulator of the IFN response. Recombinant IRF-2 (as well as the related protein IRF-1 (ref. 5)) binds the CCE specifically and activates transcription of this H4 histone gene. IRF-2 has been shown to have oncogenic potential, and our results demonstrate a link between IRF-2 and a gene that is functionally coupled to DNA replication and cell-cycle progression at the G1/S phase transition.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=7566094&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1038/377362a0
dc.subjectAnimals; Base Sequence; Cell Cycle; Cell Line; Cricetinae; DNA; DNA-Binding Proteins; *Gene Expression Regulation; Haplorhini; Hela Cells; Histones; Humans; Interferon Regulatory Factor-1; Interferon Regulatory Factor-2; Molecular Sequence Data; Phosphoproteins; *Repressor Proteins; Transcription Factors; Transcription, Genetic; Transfection
dc.subjectLife Sciences
dc.subjectMedicine and Health Sciences
dc.titleActivation of a cell-cycle-regulated histone gene by the oncogenic transcription factor IRF-2
dc.typeJournal Article
dc.source.journaltitleNature
dc.source.volume377
dc.source.issue6547
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/gsbs_sp/1306
dc.identifier.contextkey693237
html.description.abstract<p>The human histone H4 gene FO108 is regulated during the cell cycle with a peak in transcription during early S phase. The cell-cycle element (CCE) required for H4 histone activation is a sequence of 11 base pairs that binds a protein factor in electrophoretic mobility shift assays that has been designated histone nuclear factor M (HiNF-M). Here we report the purification of HiNF-M, and show it to be a protein of relative molecular mass (M(r)) 48K that is identical to interferon (IFN) regulatory factor 2 (IRF-2), a negative transcriptional regulator of the IFN response. Recombinant IRF-2 (as well as the related protein IRF-1 (ref. 5)) binds the CCE specifically and activates transcription of this H4 histone gene. IRF-2 has been shown to have oncogenic potential, and our results demonstrate a link between IRF-2 and a gene that is functionally coupled to DNA replication and cell-cycle progression at the G1/S phase transition.</p>
dc.identifier.submissionpathgsbs_sp/1306
dc.contributor.departmentDepartment of Cell Biology
dc.contributor.departmentGraduate School of Biomedical Sciences
dc.source.pages362-5


This item appears in the following Collection(s)

Show simple item record